FDA Sets Stem Cell Hearing, Asks Public For Comments On Draft Therapy Guidelines

Many clinics across the U.S. use stem cells for treatment without complying with federal regulations. This has prompted the FDA to schedule a public hearing to gather comments about drafted guidelines for stem cell therapy.